Literature DB >> 23027409

Prioritization of comparative effectiveness research topics in hospital pediatrics.

Ron Keren1, Xianqun Luan, Russell Localio, Matt Hall, Lisa McLeod, Dingwei Dai, Rajendu Srivastava.   

Abstract

OBJECTIVE: To use information about prevalence, cost, and variation in resource utilization to prioritize comparative effectiveness research topics in hospital pediatrics.
DESIGN: Retrospective analysis of administrative and billing data for hospital encounters.
SETTING: Thirty-eight freestanding US children's hospitals from January 1, 2004, through December 31, 2009. PARTICIPANTS: Children hospitalized with conditions that accounted for either 80% of all encounters or 80% of all charges. MAIN OUTCOME MEASURES: Condition-specific prevalence, total standardized cost, and interhospital variation in mean standardized cost per encounter, measured in 2 ways: (1) intraclass correlation coefficient, which represents the fraction of total variation in standardized costs per encounter due to variation between hospitals; and (2) number of outlier hospitals, defined as having more than 30% of encounters with standardized costs in either the lowest or highest quintile across all encounters.
RESULTS: Among 495 conditions accounting for 80% of all charges, the 10 most expensive conditions accounted for 36% of all standardized costs. Among the 50 most prevalent and 50 most costly conditions (77 in total), 26 had intraclass correlation coefficients higher than 0.10 and 5 had intraclass correlation coefficients higher than 0.30. For 10 conditions, more than half of the hospitals met outlier hospital criteria. Surgical procedures for hypertrophy of tonsils and adenoids, otitis media, and acute appendicitis without peritonitis were high cost, were high prevalence, and displayed significant variation in interhospital cost per encounter.
CONCLUSIONS: Detailed administrative and billing data can be used to standardize hospital costs and identify high-priority conditions for comparative effectiveness research--those that are high cost, are high prevalence, and demonstrate high variation in resource utilization.

Entities:  

Mesh:

Year:  2012        PMID: 23027409     DOI: 10.1001/archpediatrics.2012.1266

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  84 in total

1.  Biomarkers for Predicting Illness Severity in Children With Acute Lower Respiratory Tract Infections.

Authors:  Samir S Shah; Lilliam Ambroggio; Todd A Florin
Journal:  J Pediatric Infect Dis Soc       Date:  2014-05-14       Impact factor: 3.164

2.  Comparing Resource Use in Medical Admissions of Children With Complex Chronic Conditions.

Authors:  Jeffrey H Silber; Paul R Rosenbaum; Samuel D Pimentel; Shawna Calhoun; Wei Wang; James E Sharpe; Joseph G Reiter; Shivani A Shah; Lauren L Hochman; Orit Even-Shoshan
Journal:  Med Care       Date:  2019-08       Impact factor: 2.983

3.  National variation in costs and mortality for leukodystrophy patients in US children's hospitals.

Authors:  Cameron J Brimley; Jonathan Lopez; Keith van Haren; Jacob Wilkes; Xiaoming Sheng; Clint Nelson; E Kent Korgenski; Rajendu Srivastava; Joshua L Bonkowsky
Journal:  Pediatr Neurol       Date:  2013-09       Impact factor: 3.372

4.  Variation in Antibiotic Selection and Clinical Outcomes in Infants <60 Days Hospitalized With Skin and Soft Tissue Infections.

Authors:  Jessica L Markham; Matthew Hall; Mary Ann Queen; Paul L Aronson; Sowdhamini S Wallace; Dana M Foradori; Gabrielle Hester; Jennifer Nead; Michelle A Lopez; Andrea T Cruz; Russell J McCulloh
Journal:  Hosp Pediatr       Date:  2019-01

5.  Comparative effectiveness of empiric antibiotics for community-acquired pneumonia.

Authors:  Mary Ann Queen; Angela L Myers; Matthew Hall; Samir S Shah; Derek J Williams; Katherine A Auger; Karen E Jerardi; Angela M Statile; Joel S Tieder
Journal:  Pediatrics       Date:  2013-12-09       Impact factor: 7.124

6.  Incidence of Hospitalization for Vaccine-Preventable Infections in Children Following Solid Organ Transplant and Associated Morbidity, Mortality, and Costs.

Authors:  Amy G Feldman; Brenda L Beaty; Donna Curtis; Elizabeth Juarez-Colunga; Allison Kempe
Journal:  JAMA Pediatr       Date:  2019-03-01       Impact factor: 16.193

Review 7.  The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to individualize pharmacological management?

Authors:  Carlos E Rodríguez-Martínez; Jose A Castro-Rodriguez; Gustavo Nino; Fabio Midulla
Journal:  Paediatr Respir Rev       Date:  2019-04-12       Impact factor: 2.726

8.  Clinical Risk Factors for Revisits for Children With Community-Acquired Pneumonia.

Authors:  Lilliam Ambroggio; Helena Herman; Emily Fain; Guixia Huang; Todd A Florin
Journal:  Hosp Pediatr       Date:  2018-11

9.  Hospital Costs Related to Early Extubation After Infant Cardiac Surgery.

Authors:  Kimberly E McHugh; William T Mahle; Matthew A Hall; Mark A Scheurer; Michael-Alice Moga; John Triedman; Susan C Nicolson; Venugopal Amula; David S Cooper; Marcus Schamberger; Michael Wolf; Lara Shekerdemian; Kristin M Burns; Kathleen E Ash; Dustin M Hipp; Sara K Pasquali
Journal:  Ann Thorac Surg       Date:  2018-11-17       Impact factor: 4.330

10.  Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.

Authors:  Julia Shaklee Sammons; Russell Localio; Rui Xiao; Susan E Coffin; Theoklis Zaoutis
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.